ArticleOncology letters2018

Baseline prostate-specific antigen levels following treatment with abiraterone acetate as a prognostic factor in castration-resistant prostate cancer.

Tasuku Hiroshige et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.